Company / Operating Income per Share
Biogen Operating Income per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$16.31
FY2021
5-year range
$16.31 / $16.31
FY2017-FY2021
Trend
-29.3%
vs FY2020
Sector context
#5 of 199
Health Care
What the data says
Among 199 Health Care companies, Biogen is in the top 3% for operating income per share. Declined from $33.30 to $16.31 over the past 2 years.
Based on SEC 10-K filings.
16.31 in FY2021 with a 5-year CAGR of -7.1%. Top quartile in the Health Care sector.
Declined from $33.30 to $16.31 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -15.8%
- 5-Year CAGR
- -7.1%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 199This company $16.31 Sector average -$3.34
▼
+588.9% above sector average
Key checks
Key Insights
- In FY2021, operating income per share decreased 29.3% year-over-year.
- Ranks #5 out of 199 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $16.31 | -29.3% |
| FY2020 | $23.07 | -30.7% |
| FY2019 | $33.30 | +22.1% |
| FY2018 | $27.27 | +10.2% |
| FY2017 | $24.76 | +5.1% |
| FY2016 | $23.57 | +13.0% |
As of FY2021 · SEC 10-K · Updated Mar 3, 2026